U-Neuron Biomedical (ROCO:6973) PEG Ratio: N/A (As of Aug. 26, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6973 U-Neuron Biomedical Inc ROCO:6973
32 GF Score
Price NT$41.35
GF Value NT$70.22
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is U-Neuron Biomedical PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, U-Neuron Biomedical's PE Ratio without NRI is 0.00. U-Neuron Biomedical's 5-Year EBITDA growth rate is 0.00%. Therefore, U-Neuron Biomedical's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for U-Neuron Biomedical's PEG Ratio or its related term are showing as below:



ROCO:6973's PEG Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 1.725
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


U-Neuron Biomedical  (ROCO:6973) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


U-Neuron Biomedical PEG Ratio Related Terms


U-Neuron Biomedical PEG Ratio Historical Data

* Premium members only.

The historical data trend for U-Neuron Biomedical's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

U-Neuron Biomedical PEG Ratio Chart

U-Neuron Biomedical Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PEG Ratio
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

U-Neuron Biomedical Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ROCO:6973 vs VRTX, REGN, RVMD: PEG Ratio Comparison

For the Biotechnology subindustry, U-Neuron Biomedical's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


U-Neuron Biomedical PEG Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, U-Neuron Biomedical's PEG Ratio distribution charts can be found below:

* The bar in red indicates where U-Neuron Biomedical's PEG Ratio falls into.


ROCO:6973
32GF Score
U-Neuron Biomedical Inc ROCO:6973
PEG Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

U-Neuron Biomedical PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

U-Neuron Biomedical's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.

Is U-Neuron Biomedical (ROCO:6973) Overvalued in 2026?

Based on GuruFocus' analysis, U-Neuron Biomedical stock appears to be undervalued. The current stock price of NT$41.35 is trading 41.1% below its estimated GF Value™ of NT$70.22. GuruFocus considers U-Neuron Biomedical to be Possible Value Trap.

Key valuation signals for ROCO:6973:

  • PEG Ratio: N/A
  • GF Value™: NT$70.22 vs. price of NT$41.35 (41.1% below fair value)
  • GF Score™: 32/100 with 3 warning signs

No single metric tells the full story. See the ROCO:6973 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


U-Neuron Biomedical Business Description

Address Xintai 5th Road, 18th Floor-5, No. 99, Section. 1, Xizhi District, New Taipei City, TWN, 22175
U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.
32GF Score

Get the complete analysis for ROCO:6973

PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$41.35
Price
NT$70.22
GF Value